Skip to content
10-K

Annual Report

Applied BioSciences Corp.

0001477932-19-003830

← back to feed
Filed
Jul 1, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Jun 26, 2019 13.45M sh
Capex FY 2019 · Mar 31, 2019 $1.56K
Capex FY 2019 · Mar 31, 2018 $4.7K
Operating Cash Flow FY 2019 · Mar 31, 2019 −$905.05K
Operating Cash Flow FY 2019 · Mar 31, 2018 −$673.47K
Stockholders Equity FY 2019 · Mar 31, 2019 $2.13M
Stockholders Equity restated FY 2019 · Mar 31, 2018 $678.47K
Current Liabilities FY 2019 · Mar 31, 2019 $374.27K
Current Liabilities FY 2019 · Mar 31, 2018 $35.89K
Current Assets FY 2019 · Mar 31, 2019 $354.46K
Current Assets FY 2019 · Mar 31, 2018 $226.85K
Total Assets FY 2019 · Mar 31, 2019 $3.65M
Total Assets FY 2019 · Mar 31, 2018 $705.33K
Sga Expense FY 2019 · Mar 31, 2019 $2.09M
Sga Expense FY 2019 · Mar 31, 2018 $953.48K
Net Income FY 2019 · Mar 31, 2019 −$2.68M
Net Income FY 2019 · Mar 31, 2018 −$2.39M
Operating Income FY 2019 · Mar 31, 2019 −$2.65M
Operating Income restated FY 2019 · Mar 31, 2018 −$2.39M
Gross Profit FY 2019 · Mar 31, 2019 $185.29K
Gross Profit FY 2019 · Mar 31, 2018 $42.01K
Cost Of Revenue FY 2019 · Mar 31, 2019 $521.77K
Cost Of Revenue FY 2019 · Mar 31, 2018 $155.55K
Revenue FY 2019 · Mar 31, 2019 $707.06K
Revenue FY 2019 · Mar 31, 2018 $197.55K